Amount Raised
$162 Million
Round Type
Series B
BostonBiotechnologyHealth CareMedicalTherapeuticsDescription
Scorpion Therapeutics, Inc., a next-generation precision oncology company, today announced the closing of an oversubscribed Series B financing, which raised $162 million. The financing was led by Boxer Capital of Tavistock Group, EcoR1 Capital, LLC, Omega Funds and Vida Ventures, with participation from new investors Surveyor Capital (a Citadel company), Invus, Wellington Management Company, Nextech Invest, OrbiMed, Casdin Capital, LLC, Woodline Partners LP, Logos Capital, Janus Henderson Investors and other undisclosed institutional investors, as well as existing investors Atlas Venture and Abingworth. With this financing, Scorpion has raised approximately $270 million since the company was founded in the first quarter of 2020.
Quick answer
Scorpion Therapeutics raised $162 Million in a Series B round, dated January 7, 2021. Scorpion Therapeutics is based in Boston, Massachusetts, United States.
- How much did Scorpion Therapeutics raise?
- Scorpion Therapeutics raised $162 Million in a Series B round on January 7, 2021.
- What does Scorpion Therapeutics do?
- Scorpion is a pioneering clinical-stage oncology company redefining the frontier of precision medicine to deliver optimized and transformational therapies for larger populations of patients with cancer, a strategy..
- Where is Scorpion Therapeutics based and how big is it?
- Scorpion Therapeutics is based in Boston, Massachusetts, United States.
- Who are the decision-makers at Scorpion Therapeutics?
- Fundz holds 1 contact at Scorpion Therapeutics. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Medical and Therapeutics around the same time
Companies in the same sectors as Scorpion Therapeutics that raised within 45 days of this round, from Fundz verified event records.
- Acrivon Therapeutics raised $16M on February 12, 2021.
- TScan Therapeutics, Inc. raised $100M on January 28, 2021.
- TScan Therapeutics, Inc. raised $100M (Series C) on January 25, 2021.
- Faeth Therapeutics raised $30M (Funding Round) on January 11, 2021.
- Immuneering raised $37M on January 5, 2021.
- Silence Therapeutics plc raised $45M on February 18, 2021.
Who to call at Scorpion Therapeutics, and when
A new round usually means Scorpion Therapeutics is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Scorpion Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Scorpion Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Scorpion Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Scorpion Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Funding Insights
What this usually meansScorpion Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.